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ABSTRACT 
Hybridoma clone C3A8, which is a fusion product between splenic lymphocytes of Balb/c 
mice immunized with MCF7 breast carcinoma cells and SP2/0 myelomas, was produced and 
characterized. A stable clone that secreted IgM monoclonal antibody (MAb) with κ light 
chain was obtained through limiting dilutions. Cell-ELISA screening, flow cytometry 
analysis, and immunofluorescence staining revealed that the MAb C3A8 had bound 
specifically and strongly to MCF7 and HT29 but cross reacted weakly or not on HeLa cell 
line. The MAb C3A8 reacted positively with paraffin-embedded tissues of human breast and 
colon cancers but there were no positive reactions on normal tissues. Western blot analysis 
showed the MAb recognized a 55 kDa protein, which was present in the extract of MCF7 and 
HT29 cell lines. Our results demonstrated that MAb C3A8 could be used for basic and 
clinical research of breast and colon cancers. 
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